Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) EPS (Basic) (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed EPS (Basic) for 5 consecutive years, with -$1.99 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 28.16% to -$1.99 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.66 through Dec 2025, up 33.33% year-over-year, with the annual reading at -$7.66 for FY2025, 33.33% up from the prior year.
  • EPS (Basic) hit -$1.99 in Q4 2025 for Kezar Life Sciences, down from -$1.53 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.25 in Q1 2021 to a low of -$9.37 in Q4 2022.
  • Historically, EPS (Basic) has averaged -$1.93 across 5 years, with a median of -$1.7 in 2025.
  • Biggest five-year swings in EPS (Basic): crashed 3503.85% in 2022 and later surged 52.61% in 2023.
  • Year by year, EPS (Basic) stood at -$0.26 in 2021, then plummeted by 3503.85% to -$9.37 in 2022, then soared by 52.61% to -$4.44 in 2023, then soared by 37.61% to -$2.77 in 2024, then grew by 28.16% to -$1.99 in 2025.
  • Business Quant data shows EPS (Basic) for KZR at -$1.99 in Q4 2025, -$1.53 in Q3 2025, and -$1.87 in Q2 2025.